At the same time, the high expression and activity of hexokinase 2 (HK2) play a critical role in the metabolic adaptation of thyroid cancer: by binding to mitochondria, HK2 not only improves metabolic efficiency but also reduces ROS production and prevents apoptosis, significantly promoting tumor cell survival. This evidence concerns the gene HK2 and neoplasm.